Results 311 to 320 of about 602,787 (351)

The effect of ultrasound-guided drug injection at Neiguan point on the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. [PDF]

Medicine (Baltimore)
Pan R, He L, Xu W, Luo X, Qin X.
europepmc   +1 more source

A case of intramural esophageal dissection caused by vomiting during barium esophagography. [PDF]

DEN Open
Ogiso T, Ikegami S, Matsuba T, Takeuchi Y, Takayanagi M.   +4 more
europepmc   +1 more source

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting. [PDF]

BMC Cancer
Sun L, Ma J, Zhou Y, Ying X, Liang G, Pi G, Li Y, Luo Y, Bi J, He H, Peng Y.   +10 more
europepmc   +1 more source

Endometriosis Presenting as a Rare Cause of Intestinal Perforation: A Case Report With Literature Review. [PDF]

Clin Case Rep
Forouhar F, Mesbah N, Esmailpour S, Bastani P, Salimi M.   +4 more
europepmc   +1 more source

Risk factors of nausea and vomiting in patients with breast cancer undergoing chemotherapy: A retrospective study. [PDF]

Medicine (Baltimore)
Jiang T, Wang X, Zheng L, Ren T, Li Y, Li J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vomiting

Pediatrics In Review, 2013
Vomiting can be the presenting symptom of a variety of disorders, ranging from self-limited diseases to life-threatening diseases. The causes of vomiting vary with age of presentation, and pediatricians should develop the skill to identify serious conditions at the earliest stage based on the age of presentation.
Kalyan Ray, Parashette, Joseph, Croffie
openaire   +2 more sources

Nausea and Vomiting of Pregnancy

Topics in Obstetrics & Gynecology, 2019
Cases of nausea and vomiting during pregnancy are divided into physiological emesis gravidarum (morning sickness), hyperemesis gravidarum (severe nausea with persistent vomiting) and nausea or vomiting due to an underlying disease.
Chelsy Caren
semanticscholar   +1 more source

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials

Diabetes, obesity and metabolism, 2017
GLP‐1 receptor agonists (RAs) may cause nausea, vomiting or diarrhoea. The aim of this study was to assess the risk of adverse events (AEs) with GLP‐1 RAs and their relation to dose, background medication and duration of action.
Karolin Bettge, M. Kahle, Mirna Abd El Aziz, J. Meier, M. Nauck   +4 more
semanticscholar   +1 more source